Table 2.
Patients' characteristics COVID‐19
| ICU admission days* | 11.6 (5.8) |
| Days of hospital admission* | 23.2 (3.7) |
| Days mechanical ventilation* | 10.1 (5.1) |
| Tracheostomy (no n, %) | 100% |
| Prone positioning (yes, %) | 86.6% |
| APACHE II* | 11.6 (4) |
| Pa/Fi 24 h* post VM | 168.4 (87.4) |
| D‐dimer ICU admission* | 673.6 (457.8) |
| PCR admission* | 16.9 (12.4) |
| Lymphocytes admission* | 687.3 (212.4) |
| Azithromycin (yes, %) | 100% |
| Hydroxychloroquine (yes, %) | 100% |
| Lopinavir (yes, %) | 100% |
| Tocilizumab (yes, %) | 53.3% |
| Interferon beta 1β (yes, %) | 40% |
| Corticosteroid bolus (yes, %) | 80% |
APACHE, Acute Physiologic and Chronic Health Evaluation; ICU, intensive care unit.
*
Data are provided as mean and standard deviation (SD).